Ethris
PrivateLast Round
Grant
May 6, 2025
Est. Valuation
$154.58M
Total Funding Raised
$61.81M
Momentum Score
50 /100
Company Overview
Ethris is a biotechnology company that develops messenger RNA (mRNA) based therapeutics and vaccines, with a focus on respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ethris Comps
Public and private peers based on sector, stage, and business model.
Ethris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 6, 2025 | ||||
| Grant | Feb 11, 2025 | ||||
| Convertible Debt | Jun 18, 2024 | ||||
| VC Round | Jun 18, 2024 | ||||
| Grant | Feb 25, 2024 | ||||
Strategic | Dec 29, 2022 |
Key People
Founding team and executive leadership
Ethris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CEPI | Grant |
| Bill & Melinda Gates Foundation | VC Round |
| European Health and Digital Executive Agency | Grant |
| Central Innovation Program for SMEs | Grant |
| Laureus Capital | Series B |
| EU4Health Programme | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Monthly visitors increased 71% MoM, reaching 2K.
- May 6, 2025
$11.3M grant received from EU4Health Programme.
Ethris Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ethris's valuation, stock price, and market status.
